ArticleHeadache2020
Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.
Article in Headache, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.
- COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.Headache · 2020Pooled it
- Telemedicine for headache disorders in real-world practice: from patient experience to health system impact.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
- Estimating risk of reported versus theoretical drug-drug interactions in headaches medicine: an exhaustive comparison between DrugBank and FAERS database for abortive and preventive combinations.Journal of oral & facial pain and headache · 2025Article
- Telemedicine for headache follow-up: feasibility, clinical outcomes, and patient-reported experience from a prospective study.Frontiers in neurology · 2025Article
- Effectiveness of Telemedicine in Managing Health-Related Issues in the Pediatric Population: A Systematic Review.Cureus · 2024Review
- Social isolation consequences: lessons from COVID-19 pandemic in a context of dynamic lock-down in Chile.BMC public health · 2024Article
- Comprehensive list of preventative migraine headache medications without significant drug-drug interactions.Frontiers in neurology · 2024Article
- Patient Factors in the Dose Selection of Oral Sumatriptan for Acute Migraine: A Post Hoc Analysis of Two Randomized Controlled Studies.Pain and therapy · 2023Article
- Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era.Journal of pain research · 2023Review
- The impact of the COVID-19 pandemic on patients with migraine.SAGE open medicine · 2023Article
- Place of distancing measures in containing epidemics: a scoping review.The Libyan journal of medicine · 2022Article
- Post-COVID Headache: A Literature Review.Current pain and headache reports · 2022Review
- Impact of the COVID-19 pandemic on people living with migraine: Results of the MiCOAS qualitative study.Headache · 2022Article
- [Adaptation of headache units in Andalusia to the COVID-19 pandemic. Analysis of the Andalusian Neurology Society's Headache Study Group].Revista de neurologia · 2022Observational
- Chronic low back pain during COVID-19 lockdown: is there a paradox effect?European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2022Article
- High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients.Cephalalgia : an international journal of headache · 2021Article
- The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder.Journal of neurology · 2021Article
- Headache teleconsultation in the era of COVID-19: Patients' evaluation and future directions.European journal of neurology · 2021Article
- Neurological Effects of COVID-19 in Children.Pediatric clinics of North America · 2021Review
- Underuse of Behavioral Treatments for Headache: a Narrative Review Examining Societal and Cultural Factors.Journal of general internal medicine · 2021Review
Corrections and comments
- Commented on by
Authors and funding
7 authors at 7 institutions in 1 country.
Funding
Abstract
objectiveTo outline strategies for the treatment of migraine which do not require in-person visits to clinic or the emergency department, and to describe ways that health insurance companies can remove barriers to quality care for migraine.
backgroundCOVID-19 is a global pandemic causing widespread infections and death. To control the spread of infection we are called to observe "social distancing" and we have been asked to postpone any procedures which are not essential. Since procedural therapies are a mainstay of headache care, the inability to do procedures could negatively affect our patients with migraine. In this manuscript we review alternative therapies, with particular attention to those which may be contra-indicated in the setting of COVID-19 infection. DESIGN/
resultsThe manuscript reviews the use of telemedicine visits and acute, bridge, and preventive therapies for migraine. We focus on evidence-based treatment where possible, but also describe "real world" strategies which may be tried. In each section we call out areas where changes to rules from commercial health insurance companies would facilitate better migraine care.
conclusionsOur common goal as health care providers is to maximize the health and safety of our patients. Successful management of migraine with avoidance of in-person clinic and emergency department visits further benefits the current urgent societal goal of maintaining social distance to contain the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.